Association of p53 protein expression in stage I lung adenocarcinoma with reference to cytological subtypes
- 1 May 1997
- journal article
- Published by Elsevier in Human Pathology
- Vol. 28 (5) , 544-548
- https://doi.org/10.1016/s0046-8177(97)90076-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Immunohistochemical detection of p53 protein is not associated with a poor prognosis in non-small-cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Comparative analysis of p53 gene mutations and protein accumulation in human non‐small‐cell lung cancerInternational Journal of Cancer, 1995
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- An immunochemical analysis of the human nuclear phosphoprotein p53Journal of Immunological Methods, 1992
- p53 Mutations in Human CancersScience, 1991
- Increased expression of mutant forms of p53 oncogene in primary lung cancerThe Lancet, 1990
- A cell kinetic study of pulmonary adenocarcinoma by an immunoperoxidase procedure after bromodeoxyuridine labelingCancer, 1989
- p53: A Frequent Target for Genetic Abnormalities in Lung CancerScience, 1989
- A New International Staging System for Lung CancerChest, 1986
- A histochemical and ultrastructural study of adenocarcinoma of the lungThe American Journal of Surgical Pathology, 1978